Início › Leucemia Mieloide Aguda › Connecticut › Bridgeport
Ensaios clínicos de Leucemia Mieloide Aguda em Bridgeport, CT
12 estudos para Leucemia Mieloide Aguda estão buscando participantes em locais em Bridgeport e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RecrutandoFase 2
- Stony Brook University Medical Center, Stony Brook · a 18 mi de distância
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
- Stony Brook University Medical Center, Stony Brook · a 18 mi de distância
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- Stony Brook University Medical Center, Stony Brook · a 18 mi de distância
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- Stony Brook University Medical Center, Stony Brook · a 18 mi de distância
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- Stony Brook University Medical Center, Stony Brook · a 18 mi de distância
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RecrutandoFase 2
- Stony Brook University Medical Center, Stony Brook · a 18 mi de distância
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RecrutandoFase 3
- Stony Brook University Medical Center, Stony Brook · a 18 mi de distância
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RecrutandoFase 1/2
- Stony Brook University Medical Center, Stony Brook · a 18 mi de distância
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RecrutandoFase 1
- Stony Brook Cancer Center, Stony Brook · a 18 mi de distância
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)
RecrutandoEstudo observacional
- Stony Brook Cancer Center, Stony Brook · a 18 mi de distância
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RecrutandoEstudo observacional
- Stony Brook University Hospital, Stony Brook · a 18 mi de distância
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecrutandoFase 1
- Stony Brook University Hospital, Stony Brook · a 18 mi de distância
Ensaios de Leucemia Mieloide Aguda em outras cidades
- Houston, TX85 estudos
- New York City, NY51 estudos
- Boston, MA44 estudos
- Seattle, WA41 estudos
- Baldwin Park, CA40 estudos
- Columbus, OH35 estudos
- Philadelphia, PA34 estudos
- Durham, NC33 estudos
- Atlanta, GA31 estudos
- Tampa, FL29 estudos
- Chicago, IL26 estudos
- Portland, OR25 estudos
Outros estudos em Bridgeport
- Câncer de Mama21 estudos
- Câncer de Pulmão de Não Pequenas Células14 estudos
- Câncer de Pulmão13 estudos
- Doença Cardiovascular9 estudos
- Câncer (todos os tipos)8 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço8 estudos
- Câncer Metastático7 estudos
- Insuficiência Cardíaca7 estudos
- Aneurisma Cerebral6 estudos
- Mieloma Múltiplo6 estudos
- Câncer de Próstata6 estudos
- Câncer de Ovário5 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.